Melinda J. Pryor
10/585 Blackburn Road
Notting Hill, VIC 3168, Australia
Notting Hill, VIC 3168, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Validation of a severe acute respiratory syndrome coronavirus 2 microneutralization assay for evaluation of vaccine immunogenicity.
Journal: Journal of virological methods
Published: January 29, 2024
Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India: A Phase 2-3 Randomized Clinical Trial.
Journal: JAMA pediatrics
Published: July 31, 2023
A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.
Journal: Scientific reports
Published: February 10, 2023
Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study.
Journal: The Lancet regional health. Southeast Asia
Published: August 10, 2022
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial.
Journal: Lancet (London, England)
Published: July 28, 2022
Efficacy and safety of a universal influenza A vaccine (MVA-NP+M1) in adults when given after seasonal quadrivalent influenza vaccine immunisation (FLU009): a phase 2b, randomised, double-blind trial.
Journal: The Lancet. Infectious diseases
Published: July 23, 2021
Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA.
Journal: Journal of medical microbiology
Published: August 07, 2020
Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
Journal: PLoS medicine
Published: May 26, 2019
Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™).
Journal: Vaccine
Published: January 04, 2018
Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.
Journal: Bioorganic & medicinal chemistry letters
Published: July 08, 2014
Characterization of drug-resistant influenza virus A(H1N1) and A(H3N2) variants selected in vitro with laninamivir.
Journal: Antimicrobial agents and chemotherapy
Published: June 25, 2014
A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses.
Journal: The Journal of antimicrobial chemotherapy
Published: April 30, 2014
Last Updated: 09/26/2026